Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.2B | 19.0B | 20.3B | 21.7B |
Cost of revenue | 16.3B | 15.0B | 13.8B | 16.2B |
Gross profit | 3.9B | 4.0B | 6.5B | 5.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | 1.3B | 2.6B | 1.4B |
Operating income | 2.7B | 1.2B | 2.5B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 93.4M | 61.1M | 63M | 57.5M |
Other income expense | — | — | — | — |
Pretax income | 2.8B | 1.4B | 2.6B | 2.7B |
Tax provision | 762M | 370.7M | 698.3M | 722.7M |
Net income | 2.0B | 981.3M | 1.9B | 2.0B |
Basic EPS | — | 7.2 | 14.2 | 14.9 |
Diluted EPS | — | 7.2 | 14.2 | 14.9 |
Basic average shares | — | 136.4M | 136.4M | 136.4M |
Diluted average shares | — | 136.4M | 136.4M | 136.4M |
EBITDA | 3.4B | 1.9B | 3.2B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -900K | -400K | -100K | -100K |
Preferred stock dividends | 0 | 0 | 0 | 0 |